Analyst Price Target is $8.00
▲ +261.99% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Puma Biotechnology in the last 3 months. The average price target is $8.00, with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 261.99% upside from the last price of $2.21.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in Puma Biotechnology. This rating has held steady since July 2022, when it changed from a Hold consensus rating.